Rafael Pasternack
Overview
Explore the profile of Rafael Pasternack including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
51
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haggqvist I, Karha P, Kautiainen H, Snellman E, Pasternack R, Partonen T
Photochem Photobiol Sci
. 2024 Oct;
23(11):2045-2056.
PMID: 39441451
Diurnal preference to eveningness might predispose to depression. There is preliminary evidence of infrared-A (IR-A) induced whole-body hyperthermia (WBH) in the treatment of depression. In this exploratory study with 19...
2.
Haapasalo A, Pasternack R, Kautiainen H, Ylianttila L, Snellman E, Partonen T
Photochem Photobiol Sci
. 2024 May;
23(7):1229-1238.
PMID: 38748081
We investigated the effects of daily ultraviolet A1 (UV-A1, 340-400 nm) exposures on mood states (#R19055, approval on 21 October 2020). Based on our earlier findings of the influence of...
3.
Balieva F, Catton L, Clareus B, Danielsen K, Fierens F, Iversen L, et al.
Dermatol Ther (Heidelb)
. 2023 Jul;
13(8):1873-1887.
PMID: 37452929
Introduction: The purpose of this study is to explore treatment preferences and identify patient characteristics in young bio-naive adults with moderate to severe psoriasis in the Nordic countries (Norway, Finland,...
4.
Hirvonen M, Pasternack R, Lipitsa T, Vihervaara A, Harvima R, Ranta M, et al.
Skin Appendage Disord
. 2022 Jun;
8(3):221-227.
PMID: 35702276
Introduction: Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with various comorbidities and diminished quality of life (QoL). Among dermatological conditions, HS is reported to most severely diminish...
5.
Raita A, Haggqvist I, Joronen H, Nikkola V, Huotari-Orava R, Ylianttila L, et al.
J Invest Dermatol
. 2022 Feb;
142(8):2289-2291.e5.
PMID: 35143821
No abstract available.
6.
Malkonen T, Nuutinen P, Hallinen T, Soini E, Nissinen R, Wennerstom C, et al.
Acta Derm Venereol
. 2021 Dec;
102:adv00631.
PMID: 34904684
Guselkumab treatment outcomes and persistence were assessed in a real-world cohort of Finnish patients with difficult-to-treat plaque psoriasis over a median follow-up of 1 year. Data on 181 patients who...
7.
Patients with hidradenitis suppurativa may suffer from neuropathic pain: A Finnish multicenter study
Huilaja L, Hirvonen M, Lipitsa T, Vihervaara A, Harvima R, Sintonen H, et al.
J Am Acad Dermatol
. 2019 Nov;
82(5):1232-1234.
PMID: 31730843
No abstract available.
8.
Vakeva L, Niemela S, Lauha M, Pasternack R, Hannuksela-Svahn A, Hjerppe A, et al.
Photodermatol Photoimmunol Photomed
. 2019 May;
35(5):332-338.
PMID: 31063610
Background/purpose: Narrowband UVB phototherapy is a common treatment modality in psoriasis and atopic dermatitis, but evidence of its actual effect in clinical setting is sparse. Our aim was to assess...
9.
Karppinen T, Laine J, Kautiainen H, Pasternack R, Reunala T, Snellman E
Acta Derm Venereol
. 2016 Jul;
97(2):255-257.
PMID: 27383823
No abstract available.
10.
Uibu M, Pasternack R, Seppala I, Hiltunen-Back E, Reunala T
Duodecim
. 2007 Mar;
122(24):3017-21.
PMID: 17330425
No abstract available.